The function of cyclic-adenosine monophosphate responsive element-binding protein in hematologic malignancies

Bryan Mitton, Er Chieh Cho, Grace I. Aldana-Masangkay, Kathleen M. Sakamoto

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Central to discovering novel approaches to treating leukemias and lymphomas is a clear understanding of the signaling networks which lead to unchecked cell cycle progression, proliferation, and survival. Cyclic-adenosine monophosphate (cAMP) responsive element-binding protein (CREB) represents a critical integrator of numerous signals from cytoplasmic kinase cascades, and is directly involved in controlling the transcription of genes critical for normal cellular proliferation and survival. Several lines of evidence implicate CREB as a proto-oncogene, as a number of translocations involving CREB and dysregulation of expression are both associated with oncogenesis. Thus, CREB represents a potential therapeutic target in leukemia. Here, we review CREB function and regulation in normal and aberrant hematopoiesis.

Original languageEnglish
Pages (from-to)2057-2063
Number of pages7
JournalLeukemia and Lymphoma
Volume52
Issue number11
DOIs
Publication statusPublished - Nov 2011
Externally publishedYes

Fingerprint

Hematologic Neoplasms
Cyclic AMP
Carrier Proteins
Leukemia
Proto-Oncogenes
Hematopoiesis
Lymphoma
Cell Cycle
Carcinogenesis
Phosphotransferases
Cell Proliferation
Genes

Keywords

  • Cell cycle and apoptosis changes
  • Lymphoid leukemia
  • Myeloid leukemias and dysplasias
  • Signal transduction
  • Transcription factor changes

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

The function of cyclic-adenosine monophosphate responsive element-binding protein in hematologic malignancies. / Mitton, Bryan; Cho, Er Chieh; Aldana-Masangkay, Grace I.; Sakamoto, Kathleen M.

In: Leukemia and Lymphoma, Vol. 52, No. 11, 11.2011, p. 2057-2063.

Research output: Contribution to journalArticle

Mitton, Bryan ; Cho, Er Chieh ; Aldana-Masangkay, Grace I. ; Sakamoto, Kathleen M. / The function of cyclic-adenosine monophosphate responsive element-binding protein in hematologic malignancies. In: Leukemia and Lymphoma. 2011 ; Vol. 52, No. 11. pp. 2057-2063.
@article{d9a8d9e307ec477d82ebb865685dda35,
title = "The function of cyclic-adenosine monophosphate responsive element-binding protein in hematologic malignancies",
abstract = "Central to discovering novel approaches to treating leukemias and lymphomas is a clear understanding of the signaling networks which lead to unchecked cell cycle progression, proliferation, and survival. Cyclic-adenosine monophosphate (cAMP) responsive element-binding protein (CREB) represents a critical integrator of numerous signals from cytoplasmic kinase cascades, and is directly involved in controlling the transcription of genes critical for normal cellular proliferation and survival. Several lines of evidence implicate CREB as a proto-oncogene, as a number of translocations involving CREB and dysregulation of expression are both associated with oncogenesis. Thus, CREB represents a potential therapeutic target in leukemia. Here, we review CREB function and regulation in normal and aberrant hematopoiesis.",
keywords = "Cell cycle and apoptosis changes, Lymphoid leukemia, Myeloid leukemias and dysplasias, Signal transduction, Transcription factor changes",
author = "Bryan Mitton and Cho, {Er Chieh} and Aldana-Masangkay, {Grace I.} and Sakamoto, {Kathleen M.}",
year = "2011",
month = "11",
doi = "10.3109/10428194.2011.584994",
language = "English",
volume = "52",
pages = "2057--2063",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Informa Healthcare",
number = "11",

}

TY - JOUR

T1 - The function of cyclic-adenosine monophosphate responsive element-binding protein in hematologic malignancies

AU - Mitton, Bryan

AU - Cho, Er Chieh

AU - Aldana-Masangkay, Grace I.

AU - Sakamoto, Kathleen M.

PY - 2011/11

Y1 - 2011/11

N2 - Central to discovering novel approaches to treating leukemias and lymphomas is a clear understanding of the signaling networks which lead to unchecked cell cycle progression, proliferation, and survival. Cyclic-adenosine monophosphate (cAMP) responsive element-binding protein (CREB) represents a critical integrator of numerous signals from cytoplasmic kinase cascades, and is directly involved in controlling the transcription of genes critical for normal cellular proliferation and survival. Several lines of evidence implicate CREB as a proto-oncogene, as a number of translocations involving CREB and dysregulation of expression are both associated with oncogenesis. Thus, CREB represents a potential therapeutic target in leukemia. Here, we review CREB function and regulation in normal and aberrant hematopoiesis.

AB - Central to discovering novel approaches to treating leukemias and lymphomas is a clear understanding of the signaling networks which lead to unchecked cell cycle progression, proliferation, and survival. Cyclic-adenosine monophosphate (cAMP) responsive element-binding protein (CREB) represents a critical integrator of numerous signals from cytoplasmic kinase cascades, and is directly involved in controlling the transcription of genes critical for normal cellular proliferation and survival. Several lines of evidence implicate CREB as a proto-oncogene, as a number of translocations involving CREB and dysregulation of expression are both associated with oncogenesis. Thus, CREB represents a potential therapeutic target in leukemia. Here, we review CREB function and regulation in normal and aberrant hematopoiesis.

KW - Cell cycle and apoptosis changes

KW - Lymphoid leukemia

KW - Myeloid leukemias and dysplasias

KW - Signal transduction

KW - Transcription factor changes

UR - http://www.scopus.com/inward/record.url?scp=80055005790&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80055005790&partnerID=8YFLogxK

U2 - 10.3109/10428194.2011.584994

DO - 10.3109/10428194.2011.584994

M3 - Article

VL - 52

SP - 2057

EP - 2063

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 11

ER -